Assignee profile:

Immunovative Therapies, Ltd.

City:

Jerusalem

Country:

Israel

Published Applications:

28

Last publication date:

2016-07-14

Patent Grants:

25

Last grant date:

2019-06-11

Top Inventors for applications by Immunovative Therapies, Ltd.

These are the the leading inventors for applications assigned to Immunovative Therapies, Ltd.:

Recent patent applications by Immunovative Therapies, Ltd.

Immunovative Therapies, Ltd. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-07-14 ✅ Patent 10,318,712 granted on 2019-06-11
US20160203295A1
Physics

Automated device for biologic drug distribution

#2 | 2016-06-09 ✅ Patent 9,782,463 granted on 2017-10-10
US20160158328A1
Human necessities

Method for allogeneic cell therapy

#3 | 2015-07-09 ✅ Patent 10,272,143 granted on 2019-04-30
US20150190488A1
Human necessities

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

#4 | 2015-01-22 ✅ Patent 9,593,308 granted on 2017-03-14
US20150024489A1
Chemistry; metallurgy

Device for enhancing immunostimulatory capabilities of T-cells

#5 | 2014-10-02 ✅ Patent 9,511,127 granted on 2016-12-06
US20140294781A1
Human necessities

Method to formulate T-cells

#6 | 2014-07-10 ✅ Patent 9,352,001 granted on 2016-05-31
US20140193385A1
Human necessities

Method for stimulating a host immune system

#7 | 2014-06-26
US20140178334A1
Human necessities

Methods and compositions for liquidation of tumors

#8 | 2014-06-05 ✅ Patent 9,301,977 granted on 2016-04-05
US20140154278A1
Human necessities

Method for allogeneic cell therapy

#9 | 2013-08-01 ✅ Patent 10,385,315 granted on 2019-08-20
US20130195825A1
Chemistry; metallurgy

Cells expressing Th1 characteristics and cytolytic properties

#10 | 2013-07-25 ✅ Patent 9,320,794 granted on 2016-04-26
US20130189301A1
Human necessities

Ablative immunotherapy

#11 | 2013-04-25 ✅ Patent 10,350,242 granted on 2019-07-16
US20130101562A1
Human necessities

Methods for handling biological drugs containing living cells

#12 | 2013-04-25 ✅ Patent 9,233,156 granted on 2016-01-12
US20130101551A1
Human necessities

Induction of IL-12 using immunotherapy

#13 | 2013-03-14
US20130066465A1
Physics

Automated device for a biologic drug distribution

#14 | 2013-02-28 ✅ Patent 8,679,841 granted on 2014-03-25
US20130052212A1
Human necessities

Allogeneic cell compositions with cross-linked CD3/CD28

#15 | 2011-09-22 ✅ Patent 9,272,001 granted on 2016-03-01
US20110229502A1
Human necessities

Ablative immunotherapy

#16 | 2011-08-25 ✅ Patent 8,298,587 granted on 2012-10-30
US20110206708A1
Human necessities

Method for stimulating a therapeutic immune effect in a patient

#17 | 2011-08-25 ✅ Patent 8,728,534 granted on 2014-05-20
US20110206707A1
Human necessities

Method for stimulating a host immune system

#18 | 2011-07-21 ✅ Patent 8,748,580 granted on 2014-06-10
US20110177596A1
Chemistry; metallurgy

Device for enhancing immunostimulatory capabilities of T-cells

#19 | 2011-02-17 ✅ Patent 8,354,276 granted on 2013-01-15
US20110040259A1
Human necessities

T-cell compositions that elicit type I cytokine response

#20 | 2011-02-10 ✅ Patent 8,778,678 granted on 2014-07-15
US20110033435A1
Human necessities

Composition of activated CD4 cells

#21 | 2011-02-03 ✅ Patent 8,785,188 granted on 2014-07-22
US20110028912A1
Human necessities

Method to formulate T-cells

#22 | 2010-12-23 ✅ Patent 8,273,377 granted on 2012-09-25
US20100322966A1
Human necessities

Method for allogeneic cell therapy

#23 | 2010-04-08 ✅ Patent 9,695,397 granted on 2017-07-04
US20100086561A1
Human necessities

Th1 vaccination priming for active immunotherapy

#24 | 2008-11-13 ✅ Patent 7,943,180 granted on 2011-05-17
US20080279861A1
Human necessities

Method for stimulating a host immune system by administering an allogeneic cell material

#25 | 2008-11-13 ✅ Patent 8,076,135 granted on 2011-12-13
US20080279836A1
Human necessities

Method of preparing a treatment effective amount of allogeneic T-cells

#26 | 2008-05-15 ✅ Patent 7,972,594 granted on 2011-07-05
US20080112975A1
Human necessities

Ablative immunotherapy

#27 | 2008-05-15
US20080112963A1
Human necessities

Ablative immunotherapy

#28 | 2006-06-01 ✅ Patent 8,865,224 granted on 2014-10-21
US20060115487A1
Human necessities

Allogeneic cellular immunotherapy for opportunistic infection

Also check out Immunovative Therapies Ltd.'s (Jerusalem, Israel) applicant profile with 12 patent applications submitted.

AssigneeID:

14050 ⎘